OverviewThe global viral vector manufacturing market is projected to expand at a robust CAGR of approximately 20% over the forecast period, supported by multiple transformative forces reshaping the ...

ProteoNic BV, a leading provider of premium vector technology for biopharmaceutical and viral vector production, today ...

With a rate of mutation 35 percent higher than random chance, this previously unknown weakness could be a major vector for ...

Researchers demonstrated that it is feasible to encode executable payloads into synthetic DNA that, once sequenced and ...

ProteoNic BV, a leading provider of premium vector technology for biopharmaceutical and viral vector production, today announced that its proprietary 2G UNic(R) technology has been licensed by Ginkgo ...

Jenny Carlson Donnelly traveled to malaria-affected countries to test mosquitoes and save lives. Then she lost her job at U.S ...

Dutch privately-held company ProteoNic, a provider of premium vector technology for biopharmaceutical and viral vector production, today announced that its proprietary 2G UNic technology has been ...

A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...

Figure 1: Expression of reporter gene constructs derived from the gcy-5, lim-6 and lsy-6 genes. One potential explanation for our observations is that the vector backbone may dictate the packaging of ...

They manage to slow down the progression of Huntington's disease using a gene therapy treatment called AMT 130.

KMWorld recently held a webinar with Katie Selvaraj, AI strategist, SearchBlox Software, Inc, who discussed how search is evolving ...

A University of Arkansas archaeologist is part of a team that discovered the first example of ancient plague DNA in domesticated livestock.